Hongda Pharmaceutical

Donggang Hongda Pharmaceutical is a China-based pharmaceutical manufacturer focused primarily on commercial active pharmaceutical ingredients (APIs) and related chemical intermediates rather than an innovative clinical pipeline. The company is based in Donggang, Liaoning, and appears to be an active privately held business with GMP-compliant drug manufacturing operations. Public business-directory and registry sources indicate its core API portfolio includes promethazine hydrochloride, metronidazole, chlorpromazine hydrochloride, cimetidine, chlorpropamide, and additional small-molecule products and intermediates. The company also appears to engage in export activity and has described capabilities in API production, pharmaceutical intermediates, and related chemical process or equipment support. Overall, it is best characterized as a small commercial pharmaceutical/API manufacturer serving generic drug supply rather than a biotech discovery company.